From 2023, leukemia mortality in the US projected a year-on-year growth of approximately 0.54% to 0.55%, with figures rising from 23.93 thousand deaths in 2024 to 24.43 thousand in 2028. This indicates a consistent upward trend over the forecast period with a compound annual growth rate (CAGR) of roughly 0.55%.

Future trends to monitor include:

Advancements in medical research that could potentially slow mortality rates.
Healthcare policy changes that might impact treatment accessibility and outcomes.
Demographic shifts influencing the incidence of leukemia.
Introduction of innovative therapies and their potential effects on mortality statistics.